Cellectar Biosciences, Inc. insider trading
Every open-market purchase and sale by Cellectar Biosciences, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $49,996 2 trades by 2 insiders
3 months later: median −23.6% (−29.0% vs S&P 500) Insider sales, 5 years $733 1 trade by 1 insider
3 months later: median −11.6% (−9.0% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Cellectar Biosciences, Inc.’s insiders pay?
From August 22, 2014 to May 11, 2026, 12 insiders reported 22 open-market purchases and 15 sales not made under a pre-set plan in Cellectar Biosciences, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Awm Investment Company, Inc. | 10% owner | 0 | — | — | 14 | — | January 4, 2016 |
| Caruso James V | Chief Executive Officer | 5 | — | — | 0 | — | May 11, 2026 |
| Longcor Jarrod | Chief Operating Officer | 4 | — | — | 0 | — | May 11, 2026 |
| Hill Stephen A | Director | 3 | — | — | 0 | — | June 8, 2020 |
| Neis John | Director | 3 | — | — | 0 | — | November 30, 2016 |
| Hertzberg Richard | Other | 1 | — | — | 1 | — | November 1, 2016 |
| Berns Paul L | Director | 1 | — | — | 0 | — | April 21, 2016 |
| Driscoll Frederick W | Director | 1 | — | — | 0 | — | September 7, 2021 |
| Kolean Chad J | Chief Financial Officer | 1 | — | — | 0 | — | July 3, 2025 |
| Marxe Austin W & Greenhouse David M | 10% owner | 1 | — | — | 0 | — | September 8, 2014 |
| Pedder Simon | President and CEO | 1 | — | — | 0 | — | August 22, 2014 |
| Swirsky Douglas J | Director | 1 | — | — | 0 | — | September 14, 2021 |